Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabilone in Human Obesity
NCT04801641Phase 2Terminated
- Sponsor
- Center for Addiction and Mental Health
- Start
- Sep 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nabilone in obesity, sponsored by Center for Addiction and Mental Health. Started Sep 2021; status: terminated.
02
Drugs
nabilone
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04801641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04801641.